• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » DATATRAK appoints Eric J. Wilhelm as independent director

DATATRAK appoints Eric J. Wilhelm as independent director

August 17, 2016
CenterWatch Staff

DATATRAK International, a cloud-based, unified dClinical technologies and related services provider for the clinical trials industry, has announced the appointment of Eric J. Wilhelm to the board of directors as a Class II Director.

The company's board size is currently set at six directors, with three current board members serving as Class I Directors. The appointment of Dr. Wilhelm fills one of the three vacancies in Class II, whose term expires at the 2016 annual meeting of shareholders. Dr. Wilhelm was identified as a qualified candidate for the board position through outreach with shareholders. After discussions with the current directors and members of the management team at DATATRAK, Dr. Wilhelm was appointed to the board at the company's regularly scheduled board of directors meeting on August 5, 2016.

"In addition to having an incredibly innovative mind, Eric also possesses sound business and investment discipline, which is evident in his recurring ability to start up and grow profitable operating businesses that attract the attention of well established organizations in Silicon Valley," said DATATRAK Chairman Alex Tabatabai.

"More importantly, Eric has a deep and disciplined understanding of intelligent resource and capital allocation, which is an important attribute for a director to have at a company that is generating profits and balance sheet cash that must be deployed wisely in order for shareholders to obtain more than a dollar in return for every dollar deployed," added fellow Director Jim Bob Ward, who also serves as CEO and president of DATATRAK.

Dr. Wilhelm has founded several companies including the project-sharing community Instructables (acquired by Autodesk), high-altitude wind power company Makani Power (acquired by Google), the innovation and design partnership Squid Labs, and companies working on portable energy generation and healthcare. His is now the vice president of Hardware and Communities at Autodesk.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing